We are live on ! Find out more
NC

Nicholas Company Portfolio holdings

AUM $5.1B
1-Year Est. Return 8.43%
This Fund
S&P 500
This Quarter Est. Return
+8.82%
1 Year Est. Return
+8.43%
3 Year Est. Return
+54.31%
5 Year Est. Return
+77.46%
10 Year Est. Return
+337.16%
AUM
$4.75B
AUM Growth
+$308M
Cap. Flow
-$43.6M
Cap. Flow %
-0.92%
Top 10 Hldgs %
20.23%
Holding
229
New
8
Increased
75
Reduced
111
Closed
9

Sector Composition

Rank Sector Weight
1 Technology 21.32%
2 Healthcare 19%
3 Consumer Discretionary 14.42%
4 Financials 13.75%
5 Industrials 13.67%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ALXN
226
DELISTED
Alexion Pharmaceuticals
ALXN
-48,325
Closed -$4.73M
ADSW
227
DELISTED
Advanced Disposal Services Inc
ADSW
-216,005
Closed -$7.04M
CELG
228
DELISTED
Celgene Corp
CELG
-274,815
Closed -$27.3M

Similar funds

Nicholas Company's Q4 2019 Portfolio in Review

As of Q4 2019, Nicholas Company held 229 positions worth $4.75B, up 7% from $4.44B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Nicholas Company's Q4 2019 filing shows 8 new, 75 increased, 111 reduced and 9 closed positions. Its largest new stake was Paramount Global Class B: 887,550 shares worth $37.3M. The largest sale was Albemarle, an estimated $32.7M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Nicholas Company's largest Q4 2019 buy was Paramount Global Class B: 887,550 shares worth $37.3M.
  • Nicholas Company added most to Eli Lilly in Q4 2019, an estimated $6.25M increase.
  • Nicholas Company's biggest Q4 2019 reduction was Charles Schwab, cutting an estimated $20.9M.
  • Nicholas Company fully exited Albemarle in Q4 2019, selling an estimated $32.7M.
  • Nicholas Company's ten largest holdings make up 20% of its $4.75B portfolio in Q4 2019.
  • Nicholas Company opened 8 new positions and closed 9 in Q4 2019.
  • Nicholas Company's portfolio value rose 7% quarter-over-quarter to $4.75B.

Based on Nicholas Company's 13F filing for Q4 2019, filed 13 Feb 2020.